Biotricity PE Ratio 2015-2023 | BTCY

Current and historical p/e ratio for Biotricity (BTCY) from 2015 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Biotricity PE ratio as of May 15, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Biotricity PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-16 1.05 0.00
2023-12-31 1.15 $-1.39 0.00
2023-09-30 2.14 $-1.59 0.00
2023-06-30 3.83 $-1.69 0.00
2023-03-31 2.79 $-2.22 0.00
2022-12-31 2.69 $-2.40 0.00
2022-09-30 4.80 $-2.76 0.00
2022-06-30 10.62 $-3.78 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.011B $0.010B
Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.389B 20.53
Inspire Medical Systems (INSP) United States $4.746B 0.00
Axonics (AXNX) United States $3.453B 0.00
10x Genomics (TXG) United States $3.145B 0.00
IRhythm Technologies (IRTC) United States $3.129B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.985B 0.00
Hims & Hers Health (HIMS) United States $2.973B 0.00
Enovis (ENOV) United States $2.887B 21.40
Azenta (AZTA) United States $2.782B 156.36
Privia Health (PRVA) United States $2.073B 115.80
Schrodinger (SDGR) United States $1.698B 0.00
Omnicell (OMCL) United States $1.372B 47.41
Phreesia (PHR) United States $1.370B 0.00
Standard BioTools (LAB) United States $0.734B 0.00
Fulgent Genetics (FLGT) United States $0.675B 0.00
Definitive Healthcare (DH) United States $0.657B 0.00
Talkspace (TALK) United States $0.489B 0.00
Clover Health Investments (CLOV) United States $0.469B 0.00
Health Catalyst (HCAT) United States $0.400B 0.00
Pulmonx (LUNG) United States $0.362B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.303B 0.00
Butterfly Network (BFLY) United States $0.219B 0.00
P3 Health Partners (PIII) United States $0.194B 0.00
Outset Medical (OM) United States $0.184B 0.00
American Well (AMWL) United States $0.142B 0.00
TruBridge (TBRG) United States $0.134B 7.22
MSP Recovery (LIFW) United States $0.111B 0.00
111 (YI) China $0.109B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.072B 0.00
SHL Telemedicine (SHLT) Israel $0.072B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
Augmedix (AUGX) United States $0.058B 0.00
EUDA Health Holdings (EUDA) Singapore $0.058B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.046B 0.00
CareCloud (CCLD) United States $0.036B 0.00
Akili (AKLI) United States $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Cue Health (HLTH) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.015B 0.00
Syra Health (SYRA) United States $0.011B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00